Innovative
Immune Modulating
Therapies
iCell’s Novel Products Treat:
Systemic Lupus Erythematosus (Lupus)
Multiple Sclerosis (MS)
and other Chronic Autoimmune Conditions
T cell Malignancies
Acute Myeloid Leukemia (AML)
We research and develop chimeric antigen receptor engineered (CAR) cells to be first-in-class, cost effective, and life-saving.
Our Platforms :
Compound Cars (cCARs)
Non-Gene Editing CAR Technology for T-Cell Malignancies
Universal CARs
Super NK-cells
Our Core Pipeline
Our highly efficacious and safe constructs provide hope through providing desperately needed treatments for patients suffering from leukemias and lymphomas. We are approaching unmet clinical needs by the following timeline.